Literature DB >> 2438329

Identification of an antigenic epitope and receptor binding domain of human C5a.

R J Johnson, J D Tamerius, D E Chenoweth.   

Abstract

Nine different murine anti-human C5a monoclonal antibodies have been produced and characterized. They exhibit Kas for the 125I-labeled ligand that range from 0.4 to 48 X 10(8) M-1, and they display limited cross-reactivity with C5a from other species. Each of these antibodies has been found to compete with the granulocyte C5a receptor for binding site(s) on the C5a polypeptide. Exploration of the antigenic topography of C5a revealed that the immunodominant portion of this glycopolypeptide resides between residues Lys20 and Arg37, with the area surrounding Cys27 being particularly important. In addition, a specific C5a derived tryptic peptide containing these amino acid residues competes with 125I-C5a for binding to the receptor. These observations are consistent with previously published data and suggest that this area of the C5a molecule is an important part of the receptor "recognition domain", and thus plays a critical role in the C5a receptor interaction.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438329

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesis.

Authors:  K W Mollison; W Mandecki; E R Zuiderweg; L Fayer; T A Fey; R A Krause; R G Conway; L Miller; R P Edalji; M A Shallcross
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 2.  Biological properties of human C5a: selected in vitro and in vivo studies.

Authors:  K B Yancey
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

3.  Solution structure of a unique C5a semi-synthetic antagonist: implications in receptor binding.

Authors:  X Zhang; W Boyar; N Galakatos; N C Gonnella
Journal:  Protein Sci       Date:  1997-01       Impact factor: 6.725

4.  Antagonistic peptides against human anaphylatoxin C5a.

Authors:  Y Kaneko; N Okada; L Baranyi; T Azuma; H Okada
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

5.  Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.

Authors:  Caroline S Colley; Bojana Popovic; Sudharsan Sridharan; Judit E Debreczeni; David Hargeaves; Michael Fung; Ling-Ling An; Bryan Edwards; Joanne Arnold; Elizabeth England; Laura Eghobamien; Ulf Sivars; Liz Flavell; Jonathan Renshaw; Kate Wickson; Paul Warrener; Jingying Zha; Jessica Bonnell; Rob Woods; Trevor Wilkinson; Claire Dobson; Tristan J Vaughan
Journal:  MAbs       Date:  2017-10-24       Impact factor: 5.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.